Apple just announced a major upgrade for Dexcom and Apple Watch

“An exciting nugget of information for Dexcom users was hidden among more eye-catching announcements during yesterday’s Keynote Address at Apple’s WWDC (Worldwide Developers Conference) in San Jose. Near the end of his preview of the upcoming watchOS 4 software update for Apple Watch, Kevin Lynch (VP of Technology at Apple) briefly showed a slide that included Dexcom’s CGM watchface. He stated

read more

What could Apple’s “super secret” diabetes project be?

News broke earlier today from CNBC’s Christina Farr that Apple, Inc. has a small team of engineers working on creating sensors that can “non-invasively and continuously monitor blood sugar levels to better treat diabetes”. The project is allegedly far enough along in development that Apple is investigating possible regulatory pathways and performing feasibility trials at clinical sites in the Bay

read more

Medicare announces coverage criteria for Dexcom G5, but blocks use of smartphones?

Coming sooner than expected, Medicare recently clarified coverage criteria for the Dexcom G5, paving the way for Medicare to reimburse for people with both Type 1 and Type 2 Diabetes requiring intensive insulin dosing to use the Dexcom G5 mobile. Dexcom and the diabetes community heralded the exciting news, as the lack of CGM coverage for Medicare patients had previously

read more

Devices aren’t drugs: Insurance companies should not dictate diabetes technology

The diabetes community has been set ablaze after UnitedHealthcare announced an agreement for Medtronic devices to be the “preferred” in-network, durable medical equipment (DME) provider of insulin pumps. Starting July 1, 2016, UnitedHealthcare patients will be funneled toward using a Medtronic insulin pump instead of offerings from manufacturers like Tandem and Animas.

read more